Statement Of Income And Retained Earnings

Oncolys BioPharma Inc. - Filing #7609193

Concept 2022-01-01 to
2022-03-31
2021-01-01 to
2021-03-31
Statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)
-384,747,000 JPY
-349,453,000 JPY
Non-operating income
Non-operating income
39,533,000 JPY
26,516,000 JPY
Non-operating expenses
Non-operating expenses
4,415,000 JPY
26,689,000 JPY
Ordinary profit (loss)
-349,628,000 JPY
-349,626,000 JPY
Extraordinary income
Extraordinary income
21,406,000 JPY
JPY
Profit (loss) before income taxes
-328,222,000 JPY
-349,626,000 JPY
Income taxes - current
738,000 JPY
941,000 JPY
Profit (loss)
-328,960,000 JPY
-350,567,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.